These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37805539)

  • 1. Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial.
    Rasmussen MI; Hansen ML; Pellicer A; Gluud C; Dempsey E; Mintzer J; Hyttel-Sørensen S; Heuchan AM; Hagmann C; Ergenekon E; Dimitriou G; Pichler G; Naulaers G; Cheng G; Tkaczyk J; Fuchs H; Fumagalli M; Nesargi S; Fredly S; Szczapa T; Plomgaard AM; Hansen BM; Jakobsen JC; Greisen G
    Trials; 2023 Oct; 24(1):653. PubMed ID: 37805539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial.
    Vestager ML; Hansen ML; Rasmussen MI; Hahn GH; Hyttel-Sørensen S; Pellicer A; Heuchan AM; Hagmann C; Dempsey E; Dimitriou G; Pichler G; Naulaers G; Fuchs H; Tkaczyk J; Mintzer J; Fumagalli M; Nesargi S; Fredly S; Szczapa T; Gluud C; Jakobsen JC; Greisen G
    Trials; 2023 Oct; 24(1):696. PubMed ID: 37898759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial.
    Hansen ML; Pellicer A; Gluud C; Dempsey E; Mintzer J; Hyttel-Sørensen S; Heuchan AM; Hagmann C; Ergenekon E; Dimitriou G; Pichler G; Naulaers G; Cheng G; Guimarães H; Tkaczyk J; Kreutzer KB; Fumagalli M; Claris O; Lemmers P; Fredly S; Szczapa T; Austin T; Jakobsen JC; Greisen G
    Trials; 2019 Dec; 20(1):811. PubMed ID: 31888764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants.
    Olsen MH; Hansen ML; Lange T; Gluud C; Thabane L; Greisen G; Jakobsen JC;
    Trials; 2023 Nov; 24(1):737. PubMed ID: 37974280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants.
    Hansen ML; Pellicer A; Gluud C; Dempsey E; Mintzer J; Hyttel-Sorensen S; Heuchan AM; Hagmann C; Dimitriou G; Pichler G; Naulaers G; Cheng G; Vilan A; Tkaczyk J; Kreutzer KB; Fumagalli M; Claris O; Fredly S; Szczapa T; Lange T; Jakobsen JC; Greisen G
    Trials; 2019 Dec; 20(1):746. PubMed ID: 31856902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.
    Hyttel-Sorensen S; Austin T; van Bel F; Benders M; Claris O; Dempsey E; Fumagalli M; Greisen G; Grevstad B; Hagmann C; Hellström-Westas L; Lemmers P; Lindschou J; Naulaers G; van Oeveren W; Pellicer A; Pichler G; Roll C; Skoog M; Winkel P; Wolf M; Gluud C
    Trials; 2013 May; 14():120. PubMed ID: 23782447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Oximetry Monitoring in Extremely Preterm Infants.
    Hansen ML; Pellicer A; Hyttel-Sørensen S; Ergenekon E; Szczapa T; Hagmann C; Naulaers G; Mintzer J; Fumagalli M; Dimitriou G; Dempsey E; Tkaczyk J; Cheng G; Fredly S; Heuchan AM; Pichler G; Fuchs H; Nesargi S; Hahn GH; Piris-Borregas S; Širc J; Alsina-Casanova M; Stocker M; Ozkan H; Sarafidis K; Hopper AO; Karen T; Rzepecka-Weglarz B; Oguz SS; Arruza L; Memisoglu AC; Del Rio Florentino R; Baserga M; Maton P; Truttmann AC; de Las Cuevas I; Agergaard P; Zafra P; Bender L; Lauterbach R; Lecart C; de Buyst J; El-Khuffash A; Curley A; Vaccarello OO; Miletin J; Papathoma E; Vesoulis Z; Vento G; Cornette L; Lopez LS; Yasa B; Klamer A; Agosti M; Baud O; Mastretta E; Cetinkaya M; McCall K; Zeng S; Hatzidaki E; Bargiel A; Marciniak S; Gao X; Huijia L; Chalak L; Yang L; Rao SA; Xu X; Gonzalez BL; Wilinska M; Yin Z; Sadowska-Krawczenko I; Serrano-Viñuales I; Krolak-Olejnik B; Ybarra MM; Morales-Betancourt C; Korček P; Teresa-Palacio M; Mosca F; Hergenhan A; Koksal N; Tsoni K; Kadri MM; Knöpfli C; Rafinska-Wazny E; Akin MS; Nordvik T; Peng Z; Kersin SG; Thewissen L; Alarcon A; Healy D; Urlesberger B; Baş M; Baumgartner J; Skylogianni E; Karadyova V; Valverde E; Bergon-Sendin E; Kucera J; Pisoni S; Wang L; Smits A; Sanchez-Salmador R; Rasmussen MI; Olsen MH; Jensen AK; Gluud C; Jakobsen JC; Greisen G
    N Engl J Med; 2023 Apr; 388(16):1501-1511. PubMed ID: 37075142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants.
    Askie LM; Darlow BA; Davis PG; Finer N; Stenson B; Vento M; Whyte R
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011190. PubMed ID: 28398697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.
    Plomgaard AM; Alderliesten T; van Bel F; Benders M; Claris O; Cordeiro M; Dempsey E; Fumagalli M; Gluud C; Hyttel-Sorensen S; Lemmers P; Pellicer A; Pichler G; Greisen G
    Acta Paediatr; 2019 Feb; 108(2):275-281. PubMed ID: 29908039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III.
    Vestager ML; Hansen ML; Greisen G;
    Trials; 2024 Apr; 25(1):236. PubMed ID: 38575977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III.
    Hansen ML; Rasmussen MI; Rubin S; Pellicer A; Cheng G; Xu X; Zhaoqing Y; Zoffmann V; Greisen G
    Trials; 2020 Apr; 21(1):356. PubMed ID: 32326953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.
    Hyttel-Sorensen S; Pellicer A; Alderliesten T; Austin T; van Bel F; Benders M; Claris O; Dempsey E; Franz AR; Fumagalli M; Gluud C; Grevstad B; Hagmann C; Lemmers P; van Oeveren W; Pichler G; Plomgaard AM; Riera J; Sanchez L; Winkel P; Wolf M; Greisen G
    BMJ; 2015 Jan; 350():g7635. PubMed ID: 25569128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial.
    Plomgaard AM; Schwarz CE; Claris O; Dempsey EM; Fumagalli M; Hyttel-Sorensen S; Lemmers P; Pellicer A; Pichler G; Greisen G
    PLoS One; 2022; 17(1):e0262640. PubMed ID: 35073354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): an investigator-initiated, randomized, multi-center, multi-national, clinical trial on additional cerebral tissue oxygen saturation monitoring combined with defined treatment guidelines versus standard monitoring and treatment as usual in premature infants during immediate transition: study protocol for a randomized controlled trial.
    Pichler G; Baumgartner S; Biermayr M; Dempsey E; Fuchs H; Goos TG; Lista G; Lorenz L; Karpinski L; Mitra S; Kornhauser-Cerar L; Avian A; Urlesberger B; Schmölzer GM
    Trials; 2019 Mar; 20(1):178. PubMed ID: 30894226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stockholm preterm interaction-based intervention (SPIBI) - study protocol for an RCT of a 12-month parallel-group post-discharge program for extremely preterm infants and their parents.
    Baraldi E; Allodi MW; Löwing K; Smedler AC; Westrup B; Ådén U
    BMC Pediatr; 2020 Feb; 20(1):49. PubMed ID: 32007087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants?
    Schmölzer GM; Asztalos EV; Beltempo M; Boix H; Dempsey E; El-Naggar W; Finer NN; Hudson JA; Mukerji A; Law BHY; Yaskina M; Shah PS; Sheta A; Soraisham A; Tarnow-Mordi W; Vento M;
    Trials; 2024 Apr; 25(1):237. PubMed ID: 38576007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT.
    Dorling J; Hewer O; Hurd M; Bari V; Bosiak B; Bowler U; King A; Linsell L; Murray D; Omar O; Partlett C; Rounding C; Townend J; Abbott J; Berrington J; Boyle E; Embleton N; Johnson S; Leaf A; McCormick K; McGuire W; Patel M; Roberts T; Stenson B; Tahir W; Monahan M; Richards J; Rankin J; Juszczak E
    Health Technol Assess; 2020 Apr; 24(18):1-94. PubMed ID: 32342857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.
    Stock SJ; Bricker L; Norman JE; West HM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008968. PubMed ID: 27404120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smell and taste of milk during tube feeding of preterm infants: neurodevelopmental follow-up of the randomized TASTE trial, study protocol.
    Beker F; Hughes IP; Jacobs S; Liley HG; Bora S; Simcock G; Davis PG
    Trials; 2023 Apr; 24(1):290. PubMed ID: 37085869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.